Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1052425

registered interest
date	01/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy that pancreatic cancer patients receive treatment within 20 days of diagnosis.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	215608
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The NHS Long Term Plan published in January 2019 sets out the Government’s ambitions to see 55,000 more people surviving cancer for five years in England each year from 2028 and three quarters of all cancers detected at an early stage by 2028. To achieve these targets, we will need to make significant progress on survival across all cancers, including pancreatic cancer.</p><p> </p><p>NHS England will shortly be introducing a Faster Diagnostic Standard of 28 days for all cancer patients which, when taken together with the 62-day referral to treatment standard, will mean that all patients should expect to start their treatment within 34 days of diagnosis. This is a maximum, and trusts should continue to treat patients more quickly particularly where there is a strong clinical need.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:20:39 answering member 4067 label Biography information for Steve Brine
tabling member	4658 label Biography information for Alex Sobel

1054561

registered interest
date	01/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiography: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to tackle reductions in the number of applicants to radiography courses since the end of the NHS bursaries for those courses.
tabling member constituency	Westmorland and Lonsdale
tabling member printed	Tim Farron
uin	216167
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The NHS Long Term Plan, published on 7 January 2019, sets out a vital strategic framework to ensure that over the next 10 years the National Health Service will have the staff it needs.</p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care has commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce, including consideration of additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p><p> </p><p>Radiotherapy degree courses are three years in length, therefore students affected by the changes to the education funding system from 2017 will not have completed courses funded by loans to enable an assessment of the effect of the removal of bursaries on this profession.</p><p> </p><p>The Cancer Workforce Plan Phase 1, included a target of upskilling 300 more radiographers in image interpretation and reporting by 2021. Currently, 88 individuals have started training programmes towards this, 62 will start in January, and a further 150 during 2019/20.</p><p> </p><p>Phase 2 of the Cancer Workforce Plan will follow the Workforce Implementation Plan published later in 2019.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 216168 question first answered 07/02/2019 17:28:08 answering member 4067 label Biography information for Steve Brine
tabling member	1591 label Biography information for Tim Farron

1052184

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he will take to benchmark progress against the target for increasing the proportion of cancers diagnosed at stages one or two from half to three-quarters by 2028, as announced in the NHS Long Term Plan.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215175
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The NHS Long Term Plan included an ambition that 55,000 more people who are diagnosed with cancer in 2028 will survive for five years. Early diagnosis is a major determinant of cancer survival and NHS England have deliberately set the early diagnosis ambition – to diagnose 75% of cancers at stage 1 and 2 by 2028 - at a level which, under most scenarios, would be more than sufficient to meet the survival ambition. During the development of the plan, clinicians and stakeholders agreed that we should set a stretching ambition to ensure we improve the rate of diagnosis across all cancers, so many more people will survive.</p><p> </p><p>The NHS Long Term Plan sets out a number of key steps to achieve this ambition, including through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment and maximising the number of cancers that we identify through screening. Meeting this ambition will also require the National Health Service to harness new technological advances to target at risk patients more effectively; directing our research and innovation effort to the areas where the data tells us we can have the biggest impact; and mobilising the NHS so that we can adopt proven new approaches more quickly.</p><p> </p><p>Following the publication of the NHS Long Term Plan, the National Implementation Framework, to be published in the spring, will provide further information on how the Long Term Plan will be implemented. Additional details, based on local health system five year plans, will be brought together in a detailed national implementation plan in the autumn.</p><p> </p><p>We will continue to work closely with key partners and stakeholders and other voluntary sector partners, as we support the NHS to deliver the commitments set out in the Long Term Plan.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 215176 215177 question first answered 07/02/2019 13:50:19 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

1052185

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people that will be diagnosed with cancer at stages one or two by 2028 if the 75 per cent early diagnosis target is met.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215176
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The NHS Long Term Plan included an ambition that 55,000 more people who are diagnosed with cancer in 2028 will survive for five years. Early diagnosis is a major determinant of cancer survival and NHS England have deliberately set the early diagnosis ambition – to diagnose 75% of cancers at stage 1 and 2 by 2028 - at a level which, under most scenarios, would be more than sufficient to meet the survival ambition. During the development of the plan, clinicians and stakeholders agreed that we should set a stretching ambition to ensure we improve the rate of diagnosis across all cancers, so many more people will survive.</p><p> </p><p>The NHS Long Term Plan sets out a number of key steps to achieve this ambition, including through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment and maximising the number of cancers that we identify through screening. Meeting this ambition will also require the National Health Service to harness new technological advances to target at risk patients more effectively; directing our research and innovation effort to the areas where the data tells us we can have the biggest impact; and mobilising the NHS so that we can adopt proven new approaches more quickly.</p><p> </p><p>Following the publication of the NHS Long Term Plan, the National Implementation Framework, to be published in the spring, will provide further information on how the Long Term Plan will be implemented. Additional details, based on local health system five year plans, will be brought together in a detailed national implementation plan in the autumn.</p><p> </p><p>We will continue to work closely with key partners and stakeholders and other voluntary sector partners, as we support the NHS to deliver the commitments set out in the Long Term Plan.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 215175 215177 question first answered 07/02/2019 13:50:19 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

1052186

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to set targets for individual cancer types as part of the aim set out in the NHS Long Term Plan to diagnose 75 per cent of cancers at stages one or two by 2028.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215177
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The NHS Long Term Plan included an ambition that 55,000 more people who are diagnosed with cancer in 2028 will survive for five years. Early diagnosis is a major determinant of cancer survival and NHS England have deliberately set the early diagnosis ambition – to diagnose 75% of cancers at stage 1 and 2 by 2028 - at a level which, under most scenarios, would be more than sufficient to meet the survival ambition. During the development of the plan, clinicians and stakeholders agreed that we should set a stretching ambition to ensure we improve the rate of diagnosis across all cancers, so many more people will survive.</p><p> </p><p>The NHS Long Term Plan sets out a number of key steps to achieve this ambition, including through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment and maximising the number of cancers that we identify through screening. Meeting this ambition will also require the National Health Service to harness new technological advances to target at risk patients more effectively; directing our research and innovation effort to the areas where the data tells us we can have the biggest impact; and mobilising the NHS so that we can adopt proven new approaches more quickly.</p><p> </p><p>Following the publication of the NHS Long Term Plan, the National Implementation Framework, to be published in the spring, will provide further information on how the Long Term Plan will be implemented. Additional details, based on local health system five year plans, will be brought together in a detailed national implementation plan in the autumn.</p><p> </p><p>We will continue to work closely with key partners and stakeholders and other voluntary sector partners, as we support the NHS to deliver the commitments set out in the Long Term Plan.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 215175 215176 question first answered 07/02/2019 13:50:19 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

1052188

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Government's announcement of 10 August 2018 that the age for bowel cancer screening in England will be lowered from 60 to 50, what the timetable is for implementing the lower screening age; and what assessment he has made of the effect that staff shortages in endoscopy and pathology services will have on the ability to deliver bowel cancer screening from age 50.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215179
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Plans are well underway to deliver the commitment in the NHS Long Term Plan to modernise the bowel cancer screening programme; faecal immunochemical testing at 120ug/g will be integrated into the programme from April 2019.</p><p> </p><p>NHS England has committed to, over time, lowering the starting age for bowel screening from 60 currently to 50. This is being discussed by NHS England, the Department and Public Health England, and the final timetable will take into account modelling and feedback received from the system (commissioners, providers and cancer alliances).</p><p> </p><p>For a safe, sustainable and high-quality service extended to age 50 years, there is a requirement to balance workforce requirements for the current commitments and Health Education England has pledged to fund the training of 400 clinical endoscopists by 2021 to significantly increase endoscopy capacity in England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 215180 question first answered 07/02/2019 15:24:54 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

1052189

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to introduce the faecal immunochemical test for the Bowel Cancer Screening Programme.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215180
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Plans are well underway to deliver the commitment in the NHS Long Term Plan to modernise the bowel cancer screening programme; faecal immunochemical testing at 120ug/g will be integrated into the programme from April 2019.</p><p> </p><p>NHS England has committed to, over time, lowering the starting age for bowel screening from 60 currently to 50. This is being discussed by NHS England, the Department and Public Health England, and the final timetable will take into account modelling and feedback received from the system (commissioners, providers and cancer alliances).</p><p> </p><p>For a safe, sustainable and high-quality service extended to age 50 years, there is a requirement to balance workforce requirements for the current commitments and Health Education England has pledged to fund the training of 400 clinical endoscopists by 2021 to significantly increase endoscopy capacity in England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 215179 question first answered 07/02/2019 15:24:54 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

1052190

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department have made of the effect of delays to the introduction of the faecal immunochemical test to the Bowel Cancer Screening Programme on (a) the diagnosis rates of Bowel Cancer at (i) stage one, (ii) stage two, (iii) stage three and (iv) stage four and (b) the mortality rates of bowel cancer in England.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215181
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>There has been no assessment of the effect of delays to the introduction of faecal immunochemical test to the Bowel Cancer Screening Programme on the diagnosis rates of Bowel Cancer at stage one, stage two, stage three and stage four, or on the mortality rates of bowel cancer in England.</p><p> </p><p>The National Health Service in England already has a world class bowel cancer screening programme for people aged 60-74 years, with survival rates improving year on year. Regular bowel cancer screening has been shown to reduce the risk of dying from bowel cancer by 16%, and around 60% of bowel cancer patients now survive five years or more compared to around 25% 40 years ago. Over 95% of men and women survive for five years or more if their bowel cancer is diagnosed at stage one.</p><p> </p><p>The NHS Long Term Plan includes a proposal to modernise the bowel cancer screening programme to detect more cancers earlier and faecal immunochemical testing at 120ug/g will be integrated into the programme from April 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:19:47 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

1051289

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kidney Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will support the call by Kidney Cancer UK to fund research on a national screening programme for kidney cancer.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	214526
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The UK National Screening Committee (UK NSC) advises ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. Using research evidence, pilot programmes and economic evaluation, it assesses the evidence for programmes against a set of internationally recognised criteria.</p><p> </p><p>The UK NSC has not reviewed the evidence for a national screening programme for kidney cancer, however, the Committee welcomes new topic proposals via its annual call for topics which opens each year from September - December.</p><p> </p><p>Ministers carefully consider all recommendations made by the UK NSC.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:47:54 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1051291

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incinerators: Air Pollution
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether (a) his Department and (b) Public Health England (i) received and (ii) commissioned assessments of the effect on peoples' health of emissions from waste incinerators disposing of plastic.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	214451
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Public Health England (PHE) has not received or commissioned any assessments on disposing of plastic waste by incineration.</p><p> </p><p>When consulted, PHE provides an expert and independent opinion to the regulator, the Environment Agency, on the potential impacts on human health of emissions arising from existing or proposed regulated facilities, such as municipal waste incinerators (MWIs). Emissions from existing regulated facilities are closely monitored and regulated by the Environment Agency.</p><p> </p><p>PHE’s position is that well run and regulated modern MWIs are not a significant risk to public health when incinerating the general municipal waste mix which includes plastic.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:45:22 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew